Micronase and Peptic ulcer aggravated - a phase IV clinical study of FDA data

Summary:

Peptic ulcer aggravated is reported as a side effect among people who take Micronase (glyburide), especially for people who are male, 60+ old, also take Vicodin, and have Arthritis.

The phase IV clinical study analyzes which people have Peptic ulcer aggravated when taking Micronase. It is created by eHealthMe based on reports of 1,913 people who have side effects when taking Micronase from the FDA, and is updated regularly.

What is Micronase?

Micronase has active ingredients of glyburide. eHealthMe is studying from 1,922 Micronase users. Check the latest studies of Micronase.

What is Peptic ulcer aggravated?

Peptic ulcer aggravated is found to be associated with 1,491 drugs and 545 conditions by eHealthMe. Check the latest studies of Peptic ulcer aggravated.

On Jul, 13, 2026

1,913 people reported to have side effects when taking Micronase.
Among them, 15 people (0.78%) have Peptic ulcer aggravated.

Could Micronase cause Peptic ulcer aggravated?

Among these 15 people:

What is the gender of people who have Peptic ulcer aggravated when taking Micronase? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Peptic ulcer aggravated when taking Micronase? *

What are other drugs people take besides Micronase? *

What are other side effects people have besides Peptic ulcer aggravated? *

Anaemia (lack of blood): 7 people, 46.67%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 40.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 40.00%
Fall: 5 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 5 people, 33.33%
Pain In Extremity: 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Scoliosis (a medical condition in which a person's spine is curved from side to side): 4 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 4 people, 26.67%
Atherosclerosis (disorder of the arteries): 4 people, 26.67%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 26.67%
Back Pain: 3 people, 20.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 13.33%
Type 2 Diabetes: 1 person, 6.67%
Plantar Fasciitis (painful inflammatory process of the plantar fascia): 1 person, 6.67%
Impaired Gastric Emptying: 1 person, 6.67%
Depression: 1 person, 6.67%
Bone Loss: 1 person, 6.67%
Bone Density Decreased: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Micronase and have Peptic ulcer aggravated?

- Check whether Peptic ulcer aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micronase:

Micronase (1,922 reports)

Browse all side effects of Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peptic ulcer aggravated:

Peptic ulcer aggravated (1,491 drugs)

Browse all the conditions that are associated with Peptic ulcer aggravated:

Peptic ulcer aggravated (545 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Micronase) and Micronase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.